Relevance of Reactivity in Commercially Available Hepatitis C Virus Antibody Assays
AUTOR(ES)
Polywka, Susanne
FONTE
American Society for Microbiology
RESUMO
Sera from 2,148 patients were tested with a third-generation microparticle enzyme immunoassay (MEIA), a confirmatory assay, and a reverse transcription-PCR. Overall, 85.6% of reactivities were confirmed, 13.2% were shown to be unspecifically reactive, and 1.2% were indeterminate. The rate of confirmed MEIA reactivities clearly depended on the strength of the reactivity.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=87996Documentos Relacionados
- Genotype Dependence of Hepatitis C Virus Load Measurement in Commercially Available Quantitative Assays
- Study on reliability of commercially available hepatitis C virus antibody tests.
- Comparison of three commercially available assays for detection of varicella-zoster virus antibody.
- Evaluation of commercially available and in-house reverse transcription-PCR assays for detection of hepatitis G virus or GB virus C.
- Reduced antibody reactivity to hepatitis C virus antigens in hemodialysis patients coinfected with hepatitis B virus.
